Considering the prominent neural death observed in the course of AD, some studies have also attempted to clinically evaluate the levels of these proteins, resulting in contradictory findings [17-21], but alternatively, experimental and human studies have strengthened the belief that S100B is implicated in the mechanisms underlying neurodegeneration in AD [22-24]. This evidence concerns the gene S100B and Alzheimer disease.